Chemoinformaics analysis of ethyl butyrate
Molecular Weight | 116.16 | nRot | 3 |
Heavy Atom Molecular Weight | 104.064 | nRig | 1 |
Exact Molecular Weight | 116.084 | nRing | 0 |
Solubility: LogS | -1.497 | nHRing | 0 |
Solubility: LogP | 1.821 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 19.6255 |
nHD | 0 | BPOL | 14.6425 |
QED | 0.52 |
Synth | 1.597 |
Natural Product Likeliness | 0.037 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.025 |
Pgp-sub | 0.001 |
HIA | 0.002 |
CACO-2 | -4.208 |
MDCK | 0.0000386 |
BBB | 0.992 |
PPB | 0.521948 |
VDSS | 0.658 |
FU | 0.605768 |
CYP1A2-inh | 0.95 |
CYP1A2-sub | 0.701 |
CYP2c19-inh | 0.497 |
CYP2c19-sub | 0.787 |
CYP2c9-inh | 0.11 |
CYP2c9-sub | 0.643 |
CYP2d6-inh | 0.021 |
CYP2d6-sub | 0.296 |
CYP3a4-inh | 0.02 |
CYP3a4-sub | 0.253 |
CL | 10.167 |
T12 | 0.86 |
hERG | 0.03 |
Ames | 0.013 |
ROA | 0.048 |
SkinSen | 0.596 |
Carcinogencity | 0.178 |
EI | 0.988 |
Respiratory | 0.071 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.950833 |